{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:25:54Z","timestamp":1791861954342,"version":"4.3.4"},"reference-count":137,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2024.12672","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T05:35:04Z","timestamp":1722490504000},"source":"Crossref","is-referenced-by-count":8,"title":["Recent advances in lung cancer organoid (tumoroid) research (Review)"],"prefix":"10.3892","volume":"28","author":[{"given":"Qiang","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Longgang District People's Hospital of Shenzhen, Shenzhen, Guangdong 518172, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyang","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Nanchang University, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2024,8,1]]},"reference":[{"key":"key20240906093101_b1-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"key20240906093101_b2-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/s41591-021-01450-2","article-title":"Toward personalized treatment approaches for non-small-cell lung cancer","volume":"27","author":"Wang","year":"2021","journal-title":"Nat Med"},{"key":"key20240906093101_b3-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","article-title":"The 2015 World Health Organization Classification of lung tumors: Impact of genetic, clinical and radiologic advances since the 2004 classification","volume":"10","author":"Travis","year":"2015","journal-title":"J Thorac Oncol"},{"issue":"3","key":"key20240906093101_b4-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00235-0","article-title":"Small-cell lung cancer","volume":"7","author":"Rudin","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"key20240906093101_b5-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-3-030-14366-4_3","article-title":"Heterogeneity of small cell lung cancer stem cells","volume":"1139","author":"Prabavathy","year":"2019","journal-title":"Adv Exp Med Biol"},{"issue":"7","key":"key20240906093101_b6-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0939-9","article-title":"Intratumor heterogeneity comparison among different subtypes of non-small-cell lung cancer through multi-region tissue and matched ctDNA sequencing","volume":"18","author":"Zhang","year":"2019","journal-title":"Mol Cancer"},{"key":"key20240906093101_b7-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000487440","article-title":"Heterogeneity in lung cancer","volume":"85","author":"de Sousa","year":"2018","journal-title":"Pathobiology"},{"issue":"e100249","key":"key20240906093101_b8-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100249","article-title":"Tumor cell heterogeneity in small cell lung cancer (SCLC): Phenotypical and functional differences associated with Epithelial-Mesenchymal Transition (EMT) and DNA methylation changes","volume":"9","author":"Krohn","year":"2014","journal-title":"PLoS One"},{"issue":"9389372","key":"key20240906093101_b9-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9389372","article-title":"Mining the prognostic role of DNA methylation heterogeneity in lung adenocarcinoma","volume":"2022","author":"Liao","year":"2022","journal-title":"Dis Markers"},{"issue":"881207","key":"key20240906093101_b10-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.881207","article-title":"Development of a Multicellular 3D tumor model to study cellular heterogeneity and plasticity in NSCLC tumor microenvironment","volume":"12","author":"Arora","year":"2022","journal-title":"Front Oncol"},{"key":"key20240906093101_b11-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.18632\/aging.102814","article-title":"Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: Implications for immune checkpoint blockade therapy","volume":"12","author":"Wang","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"756340","key":"key20240906093101_b12-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.756340","article-title":"Identification and validation of the pyroptosis-related molecular subtypes of lung adenocarcinoma by bioinformatics and machine learning","volume":"9","author":"Liu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"key20240906093101_b13-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"e791","DOI":"10.1016\/S2666-7568(21)00255-5","article-title":"Efficacy and safety of carboplatin with nab-paclitaxel versus docetaxel in older patients with squamous non-small-cell lung cancer (CAPITAL): A randomised, multicentre, open-label, phase 3 trial","volume":"2","author":"Kogure","year":"2021","journal-title":"Lancet Healthy Longev"},{"key":"key20240906093101_b14-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.annonc.2021.01.071","article-title":"Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331(\u2606)","volume":"32","author":"Spigel","year":"2021","journal-title":"Ann Oncol"},{"key":"key20240906093101_b15-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ccr.2006.03.030","article-title":"Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines","volume":"9","author":"Lee","year":"2006","journal-title":"Cancer Cell"},{"issue":"e0125611","key":"key20240906093101_b16-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125611","article-title":"Genomic instability of osteosarcoma cell lines in culture: Impact on the prediction of metastasis relevant genes","volume":"10","author":"Muff","year":"2015","journal-title":"PLoS One"},{"key":"key20240906093101_b17-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ygeno.2016.04.003","article-title":"Changes of heterogeneous cell populations in the Ishikawa cell line during long-term culture: Proposal for an in vitro clonal evolution model of tumor cells","volume":"107","author":"Kasai","year":"2016","journal-title":"Genomics"},{"key":"key20240906093101_b18-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2020.02.006","article-title":"Breast cancer models: Engineering the tumor microenvironment","volume":"106","author":"Bahcecioglu","year":"2020","journal-title":"Acta Biomater"},{"key":"key20240906093101_b19-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.canlet.2020.01.015","article-title":"Preclinical models for neuroblastoma: Advances and challenges","volume":"474","author":"Nolan","year":"2020","journal-title":"Cancer Lett"},{"issue":"2365","key":"key20240906093101_b20-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-20886-0","article-title":"Fibroblast-associated tumour microenvironment induces vascular structure-networked tumouroid","volume":"8","author":"Lee","year":"2018","journal-title":"Sci Rep"},{"issue":"2490","key":"key20240906093101_b21-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14102490","article-title":"Three-dimensional organotypic cultures reshape the microRNAs transcriptional program in breast cancer cells","volume":"14","author":"Salinas-Vera","year":"2022","journal-title":"Cancers (Basel)"},{"key":"key20240906093101_b22-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"5259","DOI":"10.7150\/thno.29098","article-title":"Chemoresistance of cancer cells: Requirements of tumor microenvironment-mimicking in vitro models in anti-cancer drug development","volume":"8","author":"Jo","year":"2018","journal-title":"Theranostics"},{"key":"key20240906093101_b23-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1039\/c8lc00970h","article-title":"Microfluidic modelling of the tumor microenvironment for anti-cancer drug development","volume":"19","author":"Shang","year":"2019","journal-title":"Lab Chip"},{"key":"key20240906093101_b24-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"5315","DOI":"10.1158\/0008-5472.CAN-13-1069","article-title":"Patient-derived tumor xenografts: Transforming clinical samples into mouse models","volume":"73","author":"Siolas","year":"2013","journal-title":"Cancer Res"},{"key":"key20240906093101_b25-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1158\/0008-5472.CAN-13-2921-T","article-title":"High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development","volume":"74","author":"Lin","year":"2014","journal-title":"Cancer Res"},{"key":"key20240906093101_b26-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"7869","DOI":"10.1073\/pnas.1722617115","article-title":"Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy","volume":"115","author":"Xiao","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"key20240906093101_b27-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0829-z","article-title":"Applications of patient-derived tumor xenograft models and tumor organoids","volume":"13","author":"Yoshida","year":"2020","journal-title":"J Hematol Oncol"},{"key":"key20240906093101_b28-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.2147\/CMAR.S302565","article-title":"Application of animal models in cancer research: Recent progress and future prospects","volume":"13","author":"Li","year":"2021","journal-title":"Cancer Manag Res"},{"issue":"585","key":"key20240906093101_b29-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.3390\/cells8060585","article-title":"Establishment of novel gastric cancer patient-derived xenografts and cell lines: Pathological comparison between primary tumor, patient-derived, and cell-line derived xenografts","volume":"8","author":"Kuwata","year":"2019","journal-title":"Cells"},{"issue":"27","key":"key20240906093101_b30-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-020-00130-7","article-title":"Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy","volume":"4","author":"Recondo","year":"2020","journal-title":"NPJ Precis Oncol"},{"key":"key20240906093101_b31-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"915","DOI":"10.4143\/crt.2016.322","article-title":"Patient-derived xenograft models of epithelial ovarian cancer for preclinical studies","volume":"49","author":"Heo","year":"2017","journal-title":"Cancer Res Treat"},{"issue":"248","key":"key20240906093101_b32-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11040248","article-title":"The promise of Patient-derived preclinical models to accelerate the implementation of personalised medicine for children with neuroblastoma","volume":"11","author":"Tucker","year":"2021","journal-title":"J Pers Med"},{"issue":"79","key":"key20240906093101_b33-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-021-00285-x","article-title":"Establishment and characterization of immortalized human breast cancer cell lines from breast cancer patient-derived xenografts (PDX)","volume":"7","author":"Zhuang","year":"2021","journal-title":"NPJ Breast Cancer"},{"issue":"27","key":"key20240906093101_b34-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1186\/gm544","article-title":"Transcriptional dissection of pancreatic tumors engrafted in mice","volume":"6","author":"Martinez-Garcia","year":"2014","journal-title":"Genome Med"},{"issue":"3147","key":"key20240906093101_b35-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063147","article-title":"Multicellular modelling of Difficult-to-Treat gastrointestinal cancers: Current possibilities and challenges","volume":"23","author":"Hakuno","year":"2022","journal-title":"Int J Mol Sci"},{"key":"key20240906093101_b36-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4143\/crt.2017.307","article-title":"The generation and application of Patient-derived xenograft model for cancer research","volume":"50","author":"Jung","year":"2018","journal-title":"Cancer Res Treat"},{"key":"key20240906093101_b37-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1158\/2326-6066.CIR-18-0874","article-title":"An Improved Patient-derived xenograft humanized mouse model for evaluation of lung cancer immune responses","volume":"7","author":"Meraz","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"key20240906093101_b38-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1038\/s41591-019-0584-2","article-title":"A rectal cancer organoid platform to study individual responses to chemoradiation","volume":"25","author":"Ganesh","year":"2019","journal-title":"Nat Med"},{"key":"key20240906093101_b39-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.canlet.2019.04.039","article-title":"Organoid technology in cancer precision medicine","volume":"457","author":"Xia","year":"2019","journal-title":"Cancer Lett"},{"key":"key20240906093101_b40-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.stem.2019.05.005","article-title":"Engineering stem cell Self-organization to Build better organoids","volume":"24","author":"Brassard","year":"2019","journal-title":"Cell Stem Cell"},{"key":"key20240906093101_b41-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.stem.2019.10.010","article-title":"Patient-derived organoids predict chemoradiation responses of locally advanced rectal cancer","volume":"26","author":"Yao","year":"2020","journal-title":"Cell Stem Cell"},{"key":"key20240906093101_b42-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.stem.2021.03.012","article-title":"Patient-derived organoids model cervical tissue dynamics and viral oncogenesis in cervical cancer","volume":"28","author":"L\u00f5hmussaar","year":"2021","journal-title":"Cell Stem Cell"},{"key":"key20240906093101_b43-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.cell.2018.03.017","article-title":"Tumor evolution and drug response in patient-derived organoid models of bladder cancer","volume":"173","author":"Lee","year":"2018","journal-title":"Cell"},{"key":"key20240906093101_b44-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/path.5698","article-title":"Prostate cancer patient-derived organoids: Detailed outcome from a prospective cohort of 81 clinical specimens","volume":"254","author":"Servant","year":"2021","journal-title":"J Pathol"},{"issue":"e2101176","key":"key20240906093101_b45-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202101176","article-title":"Patient-derived organoids can guide personalized-therapies for patients with advanced breast cancer","volume":"8","author":"Chen","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"key20240906093101_b46-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/s12276-021-00654-3","article-title":"Gastrointestinal cancer organoids-applications in basic and translational cancer research","volume":"53","author":"Seidlitz","year":"2021","journal-title":"Exp Mol Med"},{"key":"key20240906093101_b47-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4438","article-title":"Human primary liver cancer-derived organoid cultures for disease modeling and drug screening","volume":"23","author":"Broutier","year":"2017","journal-title":"Nat Med"},{"issue":"12317","key":"key20240906093101_b48-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12017-y","article-title":"Interleukin-6 blockade attenuates lung cancer tissue construction integrated by cancer stem cells","volume":"7","author":"Ogawa","year":"2017","journal-title":"Sci Rep"},{"key":"key20240906093101_b49-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"430","DOI":"10.4149\/neo_2020_190417N346","article-title":"Patient-derived organoids of non-small cells lung cancer and their application for drug screening","volume":"67","author":"Li","year":"2020","journal-title":"Neoplasma"},{"key":"key20240906093101_b50-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ejca.2022.04.025","article-title":"The regulation of CD73 in non-small cell lung cancer","volume":"170","author":"Han","year":"2022","journal-title":"Eur J Cancer"},{"key":"key20240906093101_b51-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/annonc\/mdy542","article-title":"HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib","volume":"30","author":"Wang","year":"2019","journal-title":"Ann Oncol"},{"issue":"705888","key":"key20240906093101_b52-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.705888","article-title":"Decreased IL-6 and NK cells in Early-stage lung adenocarcinoma presenting as ground-glass opacity","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Oncol"},{"issue":"101411","key":"key20240906093101_b53-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101411","article-title":"Human Lung adenocarcinoma-derived organoid models for drug screening","volume":"23","author":"Li","year":"2020","journal-title":"iScience"},{"issue":"100239","key":"key20240906093101_b54-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2020.100239","article-title":"Protocol for generation of lung adenocarcinoma organoids from clinical samples","volume":"2","author":"Li","year":"2021","journal-title":"STAR Protoc"},{"key":"key20240906093101_b55-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1158\/1078-0432.CCR-19-1376","article-title":"Organoid cultures as preclinical models of Non-small cell lung cancer","volume":"26","author":"Shi","year":"2020","journal-title":"Clin Cancer Res"},{"key":"key20240906093101_b56-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"4497","DOI":"10.7150\/ijbs.73428","article-title":"Smoke-induced SAV1 gene promoter hypermethylation disrupts YAP negative feedback and promotes malignant progression of non-small cell lung cancer","volume":"18","author":"Liu","year":"2022","journal-title":"Int J Biol Sci"},{"issue":"e100300","key":"key20240906093101_b57-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2018100300","article-title":"Long-term expanding human airway organoids for disease modeling","volume":"38","author":"Sachs","year":"2019","journal-title":"EMBO J"},{"key":"key20240906093101_b58-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","article-title":"Generation of Tumor-Reactive T cells by Co-culture of peripheral blood lymphocytes and tumor organoids","volume":"174","author":"Dijkstra","year":"2018","journal-title":"Cell"},{"key":"key20240906093101_b59-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41596-019-0232-9","article-title":"Tumor organoid-T-cell coculture systems","volume":"15","author":"Cattaneo","year":"2020","journal-title":"Nat Protoc"},{"issue":"107588","key":"key20240906093101_b60-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107588","article-title":"Challenges in establishing pure lung cancer organoids limit their utility for personalized medicine","volume":"31","author":"Dijkstra","year":"2020","journal-title":"Cell Rep"},{"issue":"e24793","key":"key20240906093101_b61-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000024793","article-title":"Lung adenocarcinoma organoids harboring EGFR 19Del and L643V double mutations respond to osimertinib and gefitinib: A case report","volume":"100","author":"Bie","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"670825","key":"key20240906093101_b62-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.670825","article-title":"Wnt activity and cell proliferation are coupled to extracellular vesicle release in multiple organoid models","volume":"9","author":"S\u00e1ndor","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"key20240906093101_b63-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1158\/1078-0432.CCR-20-5026","article-title":"Modeling clinical responses to targeted therapies by patient-derived organoids of advanced lung adenocarcinoma","volume":"27","author":"Kim","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"3909","key":"key20240906093101_b64-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13153906","article-title":"Inhibitors targeting CDK9 show high efficacy against osimertinib and AMG510 resistant lung adenocarcinoma cells","volume":"13","author":"Padmanabhan","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"29","key":"key20240906093101_b65-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-021-00166-3","article-title":"Clinical application of a lung cancer organoid (tumoroid) culture system","volume":"5","author":"Yokota","year":"2021","journal-title":"NPJ Precis Oncol"},{"key":"key20240906093101_b66-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3892\/or.2018.6501","article-title":"Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissues","volume":"40","author":"Tamura","year":"2018","journal-title":"Oncol Rep"},{"issue":"481","key":"key20240906093101_b67-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.3390\/cells8050481","article-title":"An in vitro system for evaluating molecular targeted drugs using lung patient-derived tumor organoids","volume":"8","author":"Takahashi","year":"2019","journal-title":"Cells"},{"issue":"368","key":"key20240906093101_b68-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-03043-6","article-title":"Transcriptomic analysis of tumor tissues and organoids reveals the crucial genes regulating the proliferation of lung adenocarcinoma","volume":"19","author":"Ma","year":"2021","journal-title":"J Transl Med"},{"key":"key20240906093101_b69-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/978-1-0716-1811-0_24","article-title":"Pleural effusion aspirate for use in 3D lung cancer modeling and chemotherapy screening","volume":"2394","author":"Mazzocchi","year":"2022","journal-title":"Methods Mol Biol"},{"issue":"2581","key":"key20240906093101_b70-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22676-1","article-title":"Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a week","volume":"12","author":"Hu","year":"2021","journal-title":"Nat Commun"},{"issue":"3991","key":"key20240906093101_b71-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11867-6","article-title":"Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening","volume":"10","author":"Kim","year":"2019","journal-title":"Nat Commun"},{"key":"key20240906093101_b72-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1039\/c9lc00496c","article-title":"A one-stop microfluidic-based lung cancer organoid culture platform for testing drug sensitivity","volume":"19","author":"Jung","year":"2019","journal-title":"Lab Chip"},{"key":"key20240906093101_b73-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1111\/1759-7714.13542","article-title":"Genomic characteristics and drug screening among organoids derived from non-small cell lung cancer patients","volume":"11","author":"Chen","year":"2020","journal-title":"Thorac Cancer"},{"key":"key20240906093101_b74-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1158\/0008-5472.CAN-21-4029","article-title":"CYP4F2-catalyzed metabolism of arachidonic acid promotes stromal cell-mediated immunosuppression in non-small cell lung cancer","volume":"82","author":"Chen","year":"2022","journal-title":"Cancer Res"},{"key":"key20240906093101_b75-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1111\/1759-7714.14429","article-title":"Clinical outcomes of EGFR+\/METamp+ vs. EGFR+\/METamp-untreated patients with advanced non-small cell lung cancer","volume":"13","author":"Peng","year":"2022","journal-title":"Thorac Cancer"},{"issue":"1349","key":"key20240906093101_b76-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031349","article-title":"Establishment and long-term expansion of small cell lung cancer patient-derived tumor organoids","volume":"22","author":"Choi","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"174298","key":"key20240906093101_b77-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174298","article-title":"Discovery of a novel CDK7 inhibitor YPN-005 in small cell lung cancer","volume":"907","author":"Choi","year":"2021","journal-title":"Eur J Pharmacol"},{"issue":"788","key":"key20240906093101_b78-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040788","article-title":"Dysregulated pyrimidine biosynthesis contributes to 5-FU resistance in SCLC Patient-derived organoids but response to a novel polymeric fluoropyrimidine, CF10","volume":"12","author":"Gmeiner","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"106160","key":"key20240906093101_b79-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106160","article-title":"Therapeutic targeting ROR\u03b3 with natural product N-hydroxyapiosporamide for small cell lung cancer by reprogramming neuroendocrine fate","volume":"178","author":"Chen","year":"2022","journal-title":"Pharmacol Res"},{"key":"key20240906093101_b80-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.jtho.2022.08.002","article-title":"YES1 is a druggable oncogenic target in Small Cell Lung Cancer","volume":"17","author":"Redin","year":"2022","journal-title":"J Thorac Oncol"},{"issue":"1247125","key":"key20240906093101_b81-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1126\/science.1247125","article-title":"Organogenesis in a dish: Modeling development and disease using organoid technologies","volume":"345","author":"Lancaster","year":"2014","journal-title":"Science"},{"key":"key20240906093101_b82-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/s41551-021-00692-2","article-title":"Rapid reprogramming of tumour cells into cancer stem cells on double-network hydrogels","volume":"5","author":"Suzuka","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"key20240906093101_b83-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1080\/15384101.2018.1489180","article-title":"Rapid induction of pancreatic cancer cells to cancer stem cells via heterochromatin modulation","volume":"17","author":"Xu","year":"2018","journal-title":"Cell Cycle"},{"key":"key20240906093101_b84-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/cas.13155","article-title":"Tumor-derived spheroids: Relevance to cancer stem cells and clinical applications","volume":"108","author":"Ishiguro","year":"2017","journal-title":"Cancer Sci"},{"key":"key20240906093101_b85-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neo.2014.12.004","article-title":"Spherical cancer models in tumor biology","volume":"17","author":"Weiswald","year":"2015","journal-title":"Neoplasia"},{"issue":"e101735","key":"key20240906093101_b86-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101735","article-title":"Induction of cancer stem cell properties in colon cancer cells by defined factors","volume":"9","author":"Oshima","year":"2014","journal-title":"PLoS One"},{"key":"key20240906093101_b87-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.cell.2008.04.043","article-title":"Integration of external signaling pathways with the core transcriptional network in embryonic stem cells","volume":"133","author":"Chen","year":"2008","journal-title":"Cell"},{"key":"key20240906093101_b88-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s10495-019-01515-1","article-title":"Chemotherapeutic paclitaxel and cisplatin differentially induce pyroptosis in A549 lung cancer cells via caspase-3\/GSDME activation","volume":"24","author":"Zhang","year":"2019","journal-title":"Apoptosis"},{"issue":"503","key":"key20240906093101_b89-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03804-7","article-title":"Small-molecule inhibition of APE1 induces apoptosis, pyroptosis, and necroptosis in non-small cell lung cancer","volume":"12","author":"Long","year":"2021","journal-title":"Cell Death Dis"},{"key":"key20240906093101_b90-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.1080\/21655979.2021.1972078","article-title":"A novel pyroptosis-related lncRNA signature for prognostic prediction in patients with lung adenocarcinoma","volume":"12","author":"Song","year":"2021","journal-title":"Bioengineered"},{"key":"key20240906093101_b91-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1158\/1078-0432.CCR-16-0069","article-title":"Improving the predictive value of preclinical studies in support of radiotherapy clinical trials","volume":"22","author":"Coleman","year":"2016","journal-title":"Clin Cancer Res"},{"key":"key20240906093101_b92-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jprot.2018.01.012","article-title":"Patient derived xenografts (PDX) for personalized treatment of pancreatic cancer: Emerging allies in the war on a devastating cancer?","volume":"188","author":"Sereti","year":"2018","journal-title":"J Proteomics"},{"key":"key20240906093101_b93-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.copbio.2020.01.003","article-title":"Patient-derived xenografts (PDXs) as model systems for human cancer","volume":"63","author":"Invrea","year":"2020","journal-title":"Curr Opin Biotechnol"},{"key":"key20240906093101_b94-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1158\/1078-0432.CCR-18-0409","article-title":"A PDX\/Organoid biobank of advanced prostate cancers captures genomic and phenotypic heterogeneity for disease modeling and therapeutic screening","volume":"24","author":"Beshiri","year":"2018","journal-title":"Clin Cancer Res"},{"key":"key20240906093101_b95-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1293\/tox.2020-0007","article-title":"Patient-derived xenograft (PDX) models: Characteristics and points to consider for the process of establishment","volume":"33","author":"Fujii","year":"2020","journal-title":"J Toxicol Pathol"},{"issue":"206","key":"key20240906093101_b96-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03405-8","article-title":"Patient-derived xenograft (PDX) models, applications and challenges in cancer research","volume":"20","author":"Abdolahi","year":"2022","journal-title":"J Transl Med"},{"key":"key20240906093101_b97-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.biomaterials.2017.12.026","article-title":"Generation of matched patient-derived xenograft in vitro-in vivo models using 3D macroporous hydrogels for the study of liver cancer","volume":"159","author":"Fong","year":"2018","journal-title":"Biomaterials"},{"issue":"2778","key":"key20240906093101_b98-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59368-7","article-title":"Modelling of pancreatic cancer biology: Transcriptomic signature for 3D PDX-derived organoids and primary cell line organoid development","volume":"10","author":"Nelson","year":"2020","journal-title":"Sci Rep"},{"key":"key20240906093101_b99-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1158\/1541-7786.MCR-18-0531","article-title":"Human organoids share structural and genetic features with primary pancreatic adenocarcinoma tumors","volume":"17","author":"Romero-Calvo","year":"2019","journal-title":"Mol Cancer Res"},{"key":"key20240906093101_b100-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1055\/s-0039-1700566","article-title":"Small cell lung cancer: Advances in diagnosis and management","volume":"41","author":"Chauhan","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"key":"key20240906093101_b101-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1002\/cbin.11359","article-title":"New insights into small-cell lung cancer development and therapy","volume":"44","author":"Wang","year":"2020","journal-title":"Cell Biol Int"},{"key":"key20240906093101_b102-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.semcancer.2022.04.001","article-title":"Small cell lung cancer: Subtypes and therapeutic implications","volume":"86","author":"Wang","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"key20240906093101_b103-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ccell.2020.05.001","article-title":"MYC drives temporal evolution of small cell lung cancer subtypes by reprogramming neuroendocrine fate","volume":"38","author":"Ireland","year":"2020","journal-title":"Cancer Cell"},{"key":"key20240906093101_b104-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.6004\/jnccn.2018.0079","article-title":"NCCN Guidelines Insights: Small cell lung cancer, version 2.2018","volume":"16","author":"Kalemkerian","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"issue":"a038240","key":"key20240906093101_b105-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a038240","article-title":"Advances in small-cell lung cancer (SCLC) translational research","volume":"11","author":"Drapkin","year":"2021","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1187","key":"key20240906093101_b106-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01187","article-title":"Retinoic acid receptor-related orphan receptors: Critical roles in tumorigenesis","volume":"9","author":"Fan","year":"2018","journal-title":"Front Immunol"},{"key":"key20240906093101_b107-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"e02008","DOI":"10.1128\/AAC.02008-17","article-title":"Novel treatment of staphylococcus aureus Device-related infections using fibrinolytic agents","volume":"62","author":"Hogan","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"key20240906093101_b108-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.21873\/anticanres.15763","article-title":"Cell Dissociation enzymes affect Annexin V\/Flow-cytometric apoptotic assay outcomes After miRNA-based transient transfection","volume":"42","author":"Gobin","year":"2022","journal-title":"Anticancer Res"},{"key":"key20240906093101_b109-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0160-5402(87)90008-8","article-title":"Preparation of single smooth muscle cells from guinea pig taenia coli by combinations of purified collagenase and papain","volume":"18","author":"Maruyama","year":"1987","journal-title":"J Pharmacol Methods"},{"key":"key20240906093101_b110-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","article-title":"Glutamine addiction: A new therapeutic target in cancer","volume":"35","author":"Wise","year":"2010","journal-title":"Trends Biochem Sci"},{"key":"key20240906093101_b111-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/9780470123188.ch5","article-title":"Mechanistic issues in asparagine synthetase catalysis","volume":"72","author":"Richards","year":"1998","journal-title":"Adv Enzymol Relat Areas Mol Biol"},{"key":"key20240906093101_b112-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1101\/gad.1985910","article-title":"The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism","volume":"24","author":"Wellen","year":"2010","journal-title":"Genes Dev"},{"key":"key20240906093101_b113-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.15252\/embj.201696151","article-title":"Cancer cell metabolism: The essential role of the nonessential amino acid, glutamine","volume":"36","author":"Zhang","year":"2017","journal-title":"EMBO J"},{"key":"key20240906093101_b114-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0022-1759(93)90331-z","article-title":"The concentrations of glutamine and ammonia in commercially available cell culture media","volume":"166","author":"Heeneman","year":"1993","journal-title":"J Immunol Methods"},{"key":"key20240906093101_b115-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0168-1656(95)00196-4","article-title":"The importance of ammonia in mammalian cell culture","volume":"46","author":"Schneider","year":"1996","journal-title":"J Biotechnol"},{"key":"key20240906093101_b116-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10616-012-9468-8","article-title":"Advantages of AlaGln as an additive to cell culture medium: Use with anti-CD20 chimeric antibody-producing POTELLIGENT\u2122 CHO cell lines","volume":"65","author":"Imamoto","year":"2013","journal-title":"Cytotechnology"},{"key":"key20240906093101_b117-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.bbrc.2019.06.038","article-title":"Wnt activator CHIR99021-stimulated human dermal papilla spheroids contribute to hair follicle formation and production of reconstituted follicle-enriched human skin","volume":"516","author":"Yoshida","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"key20240906093101_b118-ETM-28-4-12672","author":"An"},{"issue":"2032","key":"key20240906093101_b119-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21062032","article-title":"Stem cell signaling pathways in the small intestine","volume":"21","author":"Takahashi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"key20240906093101_b120-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/bs.pmbts.2017.11.009","article-title":"The Central role of wnt signaling and organoid technology in personalizing anticancer therapy","volume":"153","author":"Vincan","year":"2018","journal-title":"Prog Mol Biol Transl Sci"},{"key":"key20240906093101_b121-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4111\/icu.2018.59.3.149","article-title":"Organoid culture of bladder cancer cells","volume":"59","author":"Yoshida","year":"2018","journal-title":"Investig Clin Urol"},{"key":"key20240906093101_b122-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s12079-018-0498-7","article-title":"A reproducible scaffold-free 3D organoid model to study neoplastic progression in breast cancer","volume":"13","author":"Djomehri","year":"2019","journal-title":"J Cell Commun Signal"},{"issue":"2036","key":"key20240906093101_b123-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.3390\/cells10082036","article-title":"Human blood vessel organoids penetrate human cerebral organoids and form a Vessel-like system","volume":"10","author":"Ahn","year":"2021","journal-title":"Cells"},{"key":"key20240906093101_b124-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/carcin\/bgz178","article-title":"A novel human colon signet-ring cell carcinoma organoid line: Establishment, characterization and application","volume":"41","author":"Li","year":"2020","journal-title":"Carcinogenesis"},{"issue":"103610","key":"key20240906093101_b125-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103610","article-title":"Lung cancer organoids, a promising model still with long way to go","volume":"171","author":"Ma","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20240906093101_b126-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/CEJ.0000000000000008","article-title":"Gastrin: From pathophysiology to cancer prevention and treatment","volume":"23","author":"Maddalo","year":"2014","journal-title":"Eur J Cancer Prev"},{"issue":"103440","key":"key20240906093101_b127-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103440","article-title":"A new murine esophageal organoid culture method and organoid-based model of esophageal squamous cell neoplasia","volume":"24","author":"Zheng","year":"2021","journal-title":"iScience"},{"issue":"335","key":"key20240906093101_b128-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4238-4","article-title":"Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models","volume":"18","author":"Tsai","year":"2018","journal-title":"BMC Cancer"},{"key":"key20240906093101_b129-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.cell.2020.10.023","article-title":"An organoid biobank of neuroendocrine neoplasms enables genotype-phenotype mapping","volume":"183","author":"Kawasaki","year":"2020","journal-title":"Cell"},{"key":"key20240906093101_b130-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1002\/hep.31772","article-title":"Hepatobiliary organoids and their applications for studies of liver health and disease: Are We There Yet?","volume":"74","author":"Shiota","year":"2021","journal-title":"Hepatology"},{"issue":"152","key":"key20240906093101_b131-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-022-00890-8","article-title":"Liver organoids: An in vitro 3D model for liver cancer study","volume":"12","author":"Dong","year":"2022","journal-title":"Cell Biosci"},{"key":"key20240906093101_b132-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1053\/j.gastro.2011.07.050","article-title":"Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium","volume":"141","author":"Sato","year":"2011","journal-title":"Gastroenterology"},{"key":"key20240906093101_b133-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/ncb3312","article-title":"Organoids as an in vitro model of human development and disease","volume":"18","author":"Fatehullah","year":"2016","journal-title":"Nat Cell Biol"},{"key":"key20240906093101_b134-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","article-title":"Prospective derivation of a living organoid biobank of colorectal cancer patients","volume":"161","author":"van de Wetering","year":"2015","journal-title":"Cell"},{"key":"key20240906093101_b135-ETM-28-4-12672","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.cell.2014.08.017","article-title":"Identification of multipotent luminal progenitor cells in human prostate organoid cultures","volume":"159","author":"Karthaus","year":"2014","journal-title":"Cell"},{"issue":"e18489","key":"key20240906093101_b136-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.18489","article-title":"Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening","volume":"5","author":"Verissimo","year":"2016","journal-title":"Elife"},{"issue":"2","key":"key20240906093101_b137-ETM-28-4-12672","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-019-0367-y","article-title":"Enhanced efficiency in isolation and expansion of hAMSCs via dual enzyme digestion and micro-carrier","volume":"10","author":"Gohi","year":"2020","journal-title":"Cell Biosci"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T06:31:09Z","timestamp":1725604269000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2024.12672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":137,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2024.12672","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,1]]},"article-number":"383"}}